Deborah Waterhouse is CEO at ViiV Healthcare and a member of GlaxoSmithKline’s corporate executive team. She joined GSK in 1996 and was most recently senior vice president of primary care within the company’s U.S. business, prior to which she led the U.S. vaccines business. She led the HIV business in the U.K. before heading the HIV Centre of Excellence for Pharma Europe and held international roles as general manager for Australia and New Zealand and senior vice president for Central Europe and Eastern Europe.